To include your compound in the COVID-19 Resource Center, submit it here.

Bristol-Myers completing enrollment in OCTAVE study

BMY said it will complete enrollment this week of

Read the full 99 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE